These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 19470507

  • 1. Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals.
    Sharma M, Manoharlal R, Shukla S, Puri N, Prasad T, Ambudkar SV, Prasad R.
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3256-65. PubMed ID: 19470507
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Voriconazole and multidrug resistance in Candida albicans.
    Wakieć R, Prasad R, Morschhäuser J, Barchiesi F, Borowski E, Milewski S.
    Mycoses; 2007 Mar; 50(2):109-15. PubMed ID: 17305773
    [Abstract] [Full Text] [Related]

  • 6. Fungicidal action of geraniol against Candida albicans is potentiated by abrogated CaCdr1p drug efflux and fluconazole synergism.
    Singh S, Fatima Z, Ahmad K, Hameed S.
    PLoS One; 2018 Mar; 13(8):e0203079. PubMed ID: 30157240
    [Abstract] [Full Text] [Related]

  • 7. Inhibitors of the Candida albicans Major Facilitator Superfamily Transporter Mdr1p Responsible for Fluconazole Resistance.
    Keniya MV, Fleischer E, Klinger A, Cannon RD, Monk BC.
    PLoS One; 2015 Mar; 10(5):e0126350. PubMed ID: 25951180
    [Abstract] [Full Text] [Related]

  • 8. Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative.
    Niimi K, Harding DR, Parshot R, King A, Lun DJ, Decottignies A, Niimi M, Lin S, Cannon RD, Goffeau A, Monk BC.
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1256-71. PubMed ID: 15047528
    [Abstract] [Full Text] [Related]

  • 9. Identification of Nile red as a fluorescent substrate of the Candida albicans ATP-binding cassette transporters Cdr1p and Cdr2p and the major facilitator superfamily transporter Mdr1p.
    Ivnitski-Steele I, Holmes AR, Lamping E, Monk BC, Cannon RD, Sklar LA.
    Anal Biochem; 2009 Nov 01; 394(1):87-91. PubMed ID: 19577533
    [Abstract] [Full Text] [Related]

  • 10. Synergistic interactions between β-lapachone and fluconazole in the inhibition of CaCdr2p and CaMdr1p in Candida albicans.
    Moraes DC, Reis de Sá LF, Domingos LTS, Pinto MDCFR, Soares RMA, Ferreira-Pereira A.
    Rev Iberoam Micol; 2020 Nov 01; 37(3-4):104-106. PubMed ID: 33229297
    [Abstract] [Full Text] [Related]

  • 11. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D, Coste AT.
    Antimicrob Agents Chemother; 2016 Jan 01; 60(1):229-38. PubMed ID: 26482310
    [Abstract] [Full Text] [Related]

  • 12. Jatrophanes from Euphorbia squamosa as potent inhibitors of Candida albicans multidrug transporters.
    Rawal MK, Shokoohinia Y, Chianese G, Zolfaghari B, Appendino G, Taglialatela-Scafati O, Prasad R, Di Pietro A.
    J Nat Prod; 2014 Dec 26; 77(12):2700-6. PubMed ID: 25437914
    [Abstract] [Full Text] [Related]

  • 13. Substitution of threonine-1351 in the multidrug transporter Cdr1p of Candida albicans results in hypersusceptibility to antifungal agents and threonine-1351 is essential for synergic effects of calcineurin inhibitor FK520.
    Shukla S, Ambudkar SV, Prasad R.
    J Antimicrob Chemother; 2004 Jul 26; 54(1):38-45. PubMed ID: 15190023
    [Abstract] [Full Text] [Related]

  • 14. Histatin-5 induces the reversal of Pdr5p mediated fluconazole resistance in Saccharomyces cerevisae.
    da Rocha Curvelo JA, Reis de Sá LF, Moraes DC, Soares RM, Ferreira-Pereira A.
    J Mycol Med; 2018 Mar 26; 28(1):137-142. PubMed ID: 29217144
    [Abstract] [Full Text] [Related]

  • 15. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.
    Holmes AR, Lin YH, Niimi K, Lamping E, Keniya M, Niimi M, Tanabe K, Monk BC, Cannon RD.
    Antimicrob Agents Chemother; 2008 Nov 26; 52(11):3851-62. PubMed ID: 18710914
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.
    Lempers VJ, van den Heuvel JJ, Russel FG, Aarnoutse RE, Burger DM, Brüggemann RJ, Koenderink JB.
    Antimicrob Agents Chemother; 2016 Jun 26; 60(6):3372-9. PubMed ID: 27001813
    [Abstract] [Full Text] [Related]

  • 17. Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP).
    Gupta A, Unadkat JD, Mao Q.
    J Pharm Sci; 2007 Dec 26; 96(12):3226-35. PubMed ID: 17518356
    [Abstract] [Full Text] [Related]

  • 18. Octyl gallate reduces ABC multidrug transporter CaCdr1p expression and leads to its mislocalisation in azole-resistant clinical isolates of Candida albicans.
    Singh S, Fatima Z, Hameed S.
    J Glob Antimicrob Resist; 2020 Sep 26; 22():497-503. PubMed ID: 32344123
    [Abstract] [Full Text] [Related]

  • 19. Insights into the modulatory effect of magnesium on efflux mechanisms of Candida albicans reveal inhibition of ATP binding cassette multidrug transporters and dysfunctional mitochondria.
    Hans S, Fatima Z, Hameed S.
    Biometals; 2021 Apr 26; 34(2):329-339. PubMed ID: 33394279
    [Abstract] [Full Text] [Related]

  • 20. Vanillin confers antifungal drug synergism in Candida albicans by impeding CaCdr2p driven efflux.
    Saibabu V, Fatima Z, Singh S, Khan LA, Hameed S.
    J Mycol Med; 2020 Apr 26; 30(1):100921. PubMed ID: 31937429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.